|
US6150328A
(en)
|
1986-07-01 |
2000-11-21 |
Genetics Institute, Inc. |
BMP products
|
|
US6291206B1
(en)
|
1993-09-17 |
2001-09-18 |
Genetics Institute, Inc. |
BMP receptor proteins
|
|
DE69434651T2
(de)
|
1993-12-07 |
2007-03-08 |
Genetics Institute, Inc., Cambridge |
Bmp-12, bmp-13 und diese enthaltende sehne-induzierende zusammensetzungen
|
|
WO1999061044A1
(en)
*
|
1998-05-28 |
1999-12-02 |
The Board Of Trustees Of The University Of Arkansas |
Noggin and antagonists of bone morphogenetic proteins to suppress pathologic bone resorption
|
|
DE69933044T3
(de)
*
|
1998-11-27 |
2016-11-24 |
Ucb Pharma, S.A. |
Zusammensetzungen und verfahren zur erhöhung der knochenmineralisierung
|
|
US6727224B1
(en)
|
1999-02-01 |
2004-04-27 |
Genetics Institute, Llc. |
Methods and compositions for healing and repair of articular cartilage
|
|
PT1223990E
(pt)
|
1999-10-15 |
2004-12-31 |
Fidia Advanced Biopolymers Srl |
Formulacoes de acido hialuronico para administracao de proteinas osteogenicas
|
|
EP1399023B1
(en)
|
2001-06-01 |
2008-04-30 |
Wyeth |
COMPOSITIONS FOR SYSTEMIC ADMINISTRATION OF SEQUENCES ENCODING BONE MORPHOGENETIC PROTEINS& x9;
|
|
EP1801240A1
(en)
*
|
2001-06-05 |
2007-06-27 |
Auckland Uniservices Limited |
Methods and compositions for assessment of pulmonary function and disorders
|
|
WO2002100426A1
(en)
*
|
2001-06-08 |
2002-12-19 |
Smith & Nephew Plc |
Bmp binding proteins for use in bone or cartilage regeneration
|
|
TWI267378B
(en)
|
2001-06-08 |
2006-12-01 |
Wyeth Corp |
Calcium phosphate delivery vehicles for osteoinductive proteins
|
|
GB2385052A
(en)
*
|
2002-02-05 |
2003-08-13 |
Leuven K U Res & Dev |
Treatment of spondyloarthropathies
|
|
US7193069B2
(en)
|
2002-03-22 |
2007-03-20 |
Research Association For Biotechnology |
Full-length cDNA
|
|
WO2004062621A2
(en)
*
|
2003-01-13 |
2004-07-29 |
Georgia Tech Research Corporation |
Anti-inflammatory agents and methods of their use
|
|
US9045553B2
(en)
|
2004-05-27 |
2015-06-02 |
Acceleron Pharma, Inc. |
Cerberus/Coco derivatives and uses thereof
|
|
US7833971B2
(en)
|
2006-12-08 |
2010-11-16 |
Acceleron Pharma Inc. |
Uses of cerberus, coco and derivatives thereof
|
|
AU2005247508A1
(en)
*
|
2004-05-27 |
2005-12-08 |
Acceleron Pharma Inc. |
Cerberus/coco derivatives and uses thereof
|
|
US20060269946A1
(en)
*
|
2005-05-10 |
2006-11-30 |
Young Robert P |
Methods and compositions for assessment of pulmonary function and disorders
|
|
JP2008545389A
(ja)
*
|
2005-05-19 |
2008-12-18 |
シナージェンズ バイオサイエンス リミティド |
肺機能及び肺障害の評価のための方法及び組成物
|
|
KR20080011292A
(ko)
*
|
2005-05-19 |
2008-02-01 |
시너젠즈 바이오사이언스 리미티드 |
유전자 다형 분석을 사용하여 폐암 발생 위험을 평가하는방법
|
|
EP1888779A4
(en)
*
|
2005-05-20 |
2009-06-10 |
Synergenz Bioscience Ltd |
METHOD FOR THE ANALYSIS OF POLYMORPHISMS AND USES THEREOF
|
|
EP2035030A2
(en)
*
|
2006-05-17 |
2009-03-18 |
Stryker Corporation |
Use of a soluble morphogenic protein complex for treating cartilage defects
|
|
CN105759056B
(zh)
*
|
2016-04-06 |
2017-11-14 |
四川大学华西医院 |
一种肺癌筛查试剂盒
|
|
WO2018115879A1
(en)
|
2016-12-21 |
2018-06-28 |
Mereo Biopharma 3 Limited |
Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta
|